Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
thomas.jackson@paediatrics.ox.ac.uk

Research groups

Childhood Leukaemia Research Group

Thomas Jackson

Postdoctoral Research Fellow

Recent publications

The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis.
Journal article

Muskens IS. et al, (2021), Nat Commun, 12
H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.
Journal article

Godfrey L. et al, (2021), Leukemia, 35, 90 - 106
The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia.
Journal article

Jackson TR. et al, (2021), Front Immunol, 12
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes.
Journal article

Hua P. et al, (2020), Blood, 136, 2410 - 2415
A novel human fetal liver-derived model reveals that MLL-AF4 drives a distinct fetal gene expression program in infant ALL
Journal article

Rice S. et al, (2020), bioRxiv

More publications